Skip to main content

Advertisement

Log in

Effect of thymectomy in elderly patients with non-thymomatous generalized myasthenia gravis

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Whether thymectomy is beneficial in elderly patients with myasthenia gravis (MG) is unclear. Thus, we assessed whether conducting thymectomy in MG patients aged ≥ 50 years is beneficial. This retrospective cohort study included patients with MG between 1990 and 2018. Thymectomy and control cohorts were selected from among the population of MG patients with an age at onset of ≥ 45 years and elevated concentrations of acetylcholine-receptor antibodies. Patients with evidence of thymic malignancy were excluded. Of these patients, those who underwent thymectomy at the age of ≥ 50 years were designated as the thymectomy group and those who received only medical treatment were designated as the medical treatment group. We compared the Myasthenia Gravis Foundation of America post-intervention status between the thymectomy and medical treatment groups. Landmark analysis was conducted with the landmark set at 24 months. A total of 34 and 105 patients were classified into the thymectomy and medical treatment groups, respectively. Before landmark analysis, the thymectomy group had a higher cumulative incidence of pharmacologic remission (p = 0.009) and complete stable remission (p = 0.022) than the medical treatment group. After landmark analysis, the thymectomy group had a 2.22-fold (95% confidence interval 1.01–4.80) increased chance of achieving pharmacologic remission compared to the medical treatment group after adjustment for age, sex, and disease severity. No significant difference was observed in the rate of relapse after pharmacological remission between the thymectomy (16.7%) and medical treatment groups (21.4%). In conclusion, thymectomy may have a beneficial effect in elderly patients with non-thymomatous generalized MG.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Gilhus NE (2016) Myasthenia Gravis. N Engl J Med 375:2570–2581

    Article  CAS  PubMed  Google Scholar 

  2. Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Strobel P (2013) The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 12:875–884

    Article  CAS  PubMed  Google Scholar 

  3. Kawaguchi N, Kuwabara S, Nemoto Y, Fukutake T, Arimura K, Osame M, Hattori T (2007) Effects of thymectomy on late-onset myasthenia gravis without thymoma. Clin Neurol Neurosurg 109:858–861

    Article  PubMed  Google Scholar 

  4. Soleimani A, Moayyeri A, Akhondzadeh S, Sadatsafavi M, Shalmani HT, Soltanzadeh A (2004) Frequency of myasthenic crisis in relation to thymectomy in generalized myasthenia gravis: a 17-year experience. BMC Neurol 4:12

    Article  PubMed  PubMed Central  Google Scholar 

  5. Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Strobel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BR, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Garcia Ramos GS, Verschuuren JJ, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Odenkirchen J, Sonett JR, Jaretzki A, Newsom-Davis J, Cutter GR, Group MS (2016) Randomized trial of thymectomy in Myasthenia Gravis. N Engl J Med 375:511–522

    Article  PubMed  PubMed Central  Google Scholar 

  6. Strobel P, Moritz R, Leite MI, Willcox N, Chuang WY, Gold R, Nix W, Schalke B, Kiefer R, Muller-Hermelink HK, Jaretzki Iii A, Newsom-Davis J, Marx A (2008) The ageing and myasthenic thymus: a morphometric study validating a standard procedure in the histological workup of thymic specimens. J Neuroimmunol 201–202:64–73

    Article  CAS  PubMed  Google Scholar 

  7. Romi F, Gilhus NE, Aarli JA (2006) Myasthenia gravis: disease severity and prognosis. Acta Neurol Scand Suppl 183:24–25

    Article  CAS  PubMed  Google Scholar 

  8. Romi F, Gilhus NE, Varhaug JE, Myking A, Skeie GO, Aarli JA (2002) Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis. Eur J Neurol 9:55–61

    Article  CAS  PubMed  Google Scholar 

  9. Uzawa A, Kawaguchi N, Kanai T, Himuro K, Oda F, Yoshida S, Yoshino I, Kuwabara S (2015) Two-year outcome of thymectomy in non-thymomatous late-onset myasthenia gravis. J Neurol 262:1019–1023

    Article  CAS  PubMed  Google Scholar 

  10. Jaretzki A, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16–23

    Article  PubMed  Google Scholar 

  11. Gleiss A, Oberbauer R, Heinze G (2018) An unjustified benefit: immortal time bias in the analysis of time-dependent events. Transpl Int 31:125–130

    Article  PubMed  Google Scholar 

  12. Cea G, Benatar M, Verdugo RJ, Salinas RA (2013) Thymectomy for non-thymomatous myasthenia gravis. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD008111.pub2:Cd008111

    Article  PubMed  Google Scholar 

  13. Gronseth GS, Barohn RJ (2000) Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55:7–15

    Article  CAS  PubMed  Google Scholar 

  14. Werneck LC, Cunha FM, Scola RH (2000) Myasthenia gravis: a retrospective study comparing thymectomy to conservative treatment. Acta Neurol Scand 101:41–46

    Article  CAS  PubMed  Google Scholar 

  15. Beekman R, Kuks JB, Oosterhuis HJ (1997) Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients. J Neurol 244:112–118

    Article  CAS  PubMed  Google Scholar 

  16. Beghi E, Antozzi C, Batocchi AP, Cornelio F, Cosi V, Evoli A, Lombardi M, Mantegazza R, Monticelli ML, Piccolo G et al (1991) Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients. J Neurol Sci 106:213–220

    Article  CAS  PubMed  Google Scholar 

  17. Donaldson DH, Ansher M, Horan S, Rutherford RB, Ringel SP (1990) The relationship of age to outcome in myasthenia gravis. Neurology 40:786–790

    Article  CAS  PubMed  Google Scholar 

  18. Evoli A, Batocchi AP, Minisci C, Di Schino C, Tonali P (2000) Clinical characteristics and prognosis of myasthenia gravis in older people. J Am Geriatr Soc 48:1442–1448

    Article  CAS  PubMed  Google Scholar 

  19. Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14:1023–1036

    Article  CAS  PubMed  Google Scholar 

  20. de Perrot M, Licker M, Spiliopoulos A (2001) Factors influencing improvement and remission rates after thymectomy for myasthenia gravis. Respiration 68:601–605

    Article  PubMed  Google Scholar 

  21. El-Medany Y, Hajjar W, Essa M, Al-Kattan K, Hariri Z, Ashour M (2003) Predictors of outcome for myasthenia gravis after thymectomy. Asian Cardiovasc Thorac Ann 11:323–327

    Article  PubMed  Google Scholar 

  22. Mantegazza R, Baggi F, Bernasconi P, Antozzi C, Confalonieri P, Novellino L, Spinelli L, Ferro MT, Beghi E, Cornelio F (2003) Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy (T-3b) in non-thymomatous myasthenia gravis patients: remission after 6 years of follow-up. J Neurol Sci 212:31–36

    Article  PubMed  Google Scholar 

  23. Tansel T, Onursal E, Barlas S, Tireli E, Alpagut U (2003) Results of surgical treatment for nonthymomatous myasthenia gravis. Surg Today 33:666–670

    Article  PubMed  Google Scholar 

  24. Nakahara K, Nakane S, Nakajima M, Yamashita S, Mori T, Ando Y (2017) Effect of thymectomy for thymic atrophy in myasthenia gravis: a retrospective study on 93 patients. J Neuroimmunol 305:182–185

    Article  CAS  PubMed  Google Scholar 

  25. Chen Z, Luo H, Peng Y, Cai L, Zhang J, Su C, Zou J (2011) Comparative clinical features and immune responses after extended thymectomy for myasthenia gravis in patients with atrophic versus hyperplastic thymus. Ann Thoracic Surg 91:212–218

    Article  Google Scholar 

  26. Pirronti T, Rinaldi P, Batocchi AP, Evoli A, Di Schino C, Marano P (2002) Thymic lesions and myasthenia gravis. Diagnosis based on mediastinal imaging and pathological findings. Acta Radiol 43:380–384

    Article  CAS  PubMed  Google Scholar 

  27. Priola AM, Priola SM (2014) Imaging of thymus in myasthenia gravis: from thymic hyperplasia to thymic tumor. Clin Radiol 69:e230–e245

    Article  CAS  Google Scholar 

  28. Nicolaou S, Muller NL, Li DK, Oger JJ (1996) Thymus in myasthenia gravis: comparison of CT and pathologic findings and clinical outcome after thymectomy. Radiology 201:471–474

    Article  CAS  PubMed  Google Scholar 

  29. Ishii W, Matsuda M, Hanyuda M, Momose M, Nakayama J, Ehara T, Ikeda S (2007) Comparison of the histological and immunohistochemical features of the thymus in young- and elderly-onset myasthenia gravis without thymoma. J Clin Neurosci 14:110–115

    Article  CAS  PubMed  Google Scholar 

  30. Marx A, Pfister F, Schalke B, Nix W, Strobel P (2012) Thymus pathology observed in the MGTX trial. Ann N Y Acad Sci 1275:92–100

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Research Foundation of Korea funded by the Korean government (MSIP) (No. 2016R1C1B1010120).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ha Young Shin.

Ethics declarations

Conflicts of interest

None of the authors has any conflicts of interest to disclose.

Ethics approval

The study including human participants has been approved by the Severance Hospital Institutional Review Board (Approval No. 4-2018-0869) and has, therefore, been performed in accordance with the Declaration of Helsinki.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 35 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, S.W., Choi, YC., Kim, S.M. et al. Effect of thymectomy in elderly patients with non-thymomatous generalized myasthenia gravis. J Neurol 266, 960–968 (2019). https://doi.org/10.1007/s00415-019-09222-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-019-09222-2

Keywords

Navigation